Alps Advisors Inc Medpace Holdings, Inc. Transaction History

Alps Advisors Inc

  • $14.8 Billion
  • Q3 2024

A detailed history of Alps Advisors Inc transactions in Medpace Holdings, Inc. stock. As of the latest transaction made, Alps Advisors Inc holds 998 shares of MEDP stock, worth $350,168. This represents 0.0% of its overall portfolio holdings.

Number of Shares
998
Previous 858 16.32%
Holding current value
$350,168
Previous $353,000 5.95%
% of portfolio
0.0%
Previous 0.0%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024
BUY
$320.58 - $457.29 $44,881 - $64,020
140 Added 16.32%
998 $332,000
Q1 2024

May 14, 2024
SELL
$284.87 - $413.31 $82,327 - $119,446
-289 Reduced 25.2%
858 $346,000
Q4 2023

Feb 14, 2024
SELL
$227.52 - $312.68 $14,788 - $20,324
-65 Reduced 5.36%
1,147 $351,000
Q3 2023

Nov 14, 2023
SELL
$233.98 - $281.67 $140,154 - $168,720
-599 Reduced 33.08%
1,212 $293,000
Q2 2023

Aug 14, 2023
BUY
$187.26 - $240.17 $1,872 - $2,401
10 Added 0.56%
1,811 $434,000
Q1 2023

May 10, 2023
SELL
$174.31 - $239.52 $45,669 - $62,754
-262 Reduced 12.7%
1,801 $338,000
Q4 2022

Feb 14, 2023
SELL
$153.06 - $226.57 $765 - $1,132
-5 Reduced 0.24%
2,063 $438,000
Q3 2022

Nov 14, 2022
BUY
$145.13 - $182.49 $300,128 - $377,389
2,068 New
2,068 $325,000
Q1 2022

May 16, 2022
SELL
$138.87 - $214.31 $282,183 - $435,477
-2,032 Closed
0 $0
Q4 2021

Feb 09, 2022
BUY
$182.74 - $227.9 $4,568 - $5,697
25 Added 1.25%
2,032 $442,000
Q3 2021

Nov 15, 2021
SELL
$170.18 - $198.21 $13,274 - $15,460
-78 Reduced 3.74%
2,007 $380,000
Q1 2021

May 07, 2021
SELL
$132.02 - $168.26 $12,805 - $16,321
-97 Reduced 4.45%
2,085 $342,000
Q4 2020

Feb 03, 2021
SELL
$109.38 - $149.19 $7,219 - $9,846
-66 Reduced 2.94%
2,182 $304,000
Q3 2020

Nov 04, 2020
SELL
$92.95 - $130.61 $49,728 - $69,876
-535 Reduced 19.22%
2,248 $251,000
Q2 2020

Aug 05, 2020
SELL
$68.08 - $95.68 $21,036 - $29,565
-309 Reduced 9.99%
2,783 $259,000
Q1 2020

May 06, 2020
SELL
$61.71 - $101.95 $60,537 - $100,012
-981 Reduced 24.09%
3,092 $227,000
Q4 2019

Feb 07, 2020
SELL
$70.08 - $84.64 $12,404 - $14,981
-177 Reduced 4.16%
4,073 $342,000
Q3 2019

Nov 04, 2019
SELL
$62.38 - $85.89 $185,268 - $255,093
-2,970 Reduced 41.14%
4,250 $357,000
Q2 2019

Aug 07, 2019
SELL
$53.64 - $65.42 $20,383 - $24,859
-380 Reduced 5.0%
7,220 $472,000
Q1 2019

May 01, 2019
BUY
$49.38 - $70.58 $25,529 - $36,489
517 Added 7.3%
7,600 $448,000
Q4 2018

Feb 04, 2019
SELL
$46.97 - $63.98 $27,571 - $37,556
-587 Reduced 7.65%
7,083 $375,000
Q3 2018

Oct 25, 2018
BUY
$43.25 - $63.74 $331,727 - $488,885
7,670 New
7,670 $460,000

Others Institutions Holding MEDP

# of Institutions
615
Shares Held
25M
Call Options Held
42.8K
Put Options Held
207K
View Full List

About Medpace Holdings, Inc.

MEDP Quotes by TradingView
  • Ticker MEDP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 31,099,900
  • Market Cap $10.9B
  • Description
  • Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...
More about MEDP
Track This Portfolio

Track Alps Advisors Inc Portfolio

Follow Alps Advisors Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alps Advisors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Alps Advisors Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email